Preview Mode Links will not work in preview mode

Apr 22, 2021

Featuring slide presentations and related discussion from Drs Matthew S Davids and Jennifer Woyach, including the following topics:

  • Recent Advances with BTK Inhibitors in the Treatment of CLL — Matthew S Davids, MD, MMSc (0:00)
  • Bcl-2 Inhibitors, PI3K Inhibitors and CAR T-Cell Regimens — Jennifer Woyach, MD...


Apr 22, 2021

Featuring perspectives from Drs Matthew S Davids and Jennifer Woyach on the following topics:

  • Introduction (0:00)
  • Recent advances with BTK inhibitors in the treatment of chronic lymphocytic leukemia (CLL) (1:03)
  • Role of Bcl-2 inhibitor-based regimens in therapy for CLL (42:59)
  • Novel strategies – U2 regimen...


Apr 21, 2021

Proceedings from part 4 of a 4-part webinar series. Featuring perspectives from Drs Paul M Barr, Matthew S Davids and Kerry Rogers, including the following topics:

  • Introduction (0:00)
  • Available and emerging data with Bruton tyrosine kinase inhibitors for chronic lymphocytic leukemia (CLL) (0:53)
  • Role of Bcl-2...


Apr 19, 2021

Proceedings from part 3 of a 4-part webinar series. Featuring perspectives from Drs Robert Z Orlowski, S Vincent Rajkumar and Edward A Stadtmauer, including the following topics:

  • Introduction (0:00)
  • Up-front management of multiple myeloma (MM) (0:52)
  • Treatment options for relapsed/refractory (R/R) MM (19:21)
  • Efficacy...


Apr 18, 2021

Proceedings from part 2 of a 4-part webinar series. Featuring perspectives from Drs John Kuruvilla, John P Leonard and Michael E Williams, including the following topics:

  • Introduction (0:00)
  • Evolving treatment paradigm for patients with diffuse large B-cell lymphoma (DLBCL) (3:33)
  • Optimal management of newly diagnosed...